Tag: Pfizer

FILE - This Friday May 2, 2014 file photo shows an exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London. The board of AstraZeneca has rejected the improved $119 billion takeover offer from U.S. drugmaker Pfizer, Monday May 19, 2014, a decision that has caused a sharp slide in the U.K. company's share price as investors think it effectively brings an end to the protracted and increasingly bitter takeover saga. (AP Photo/Matt Dunham, File)

AstraZeneca rejects $119 billion offer from Pfizer

Washington Examiner · May 19, 2014 4:14 pm

Pfizer raises offer, highlighting flurry of deals

Pfizer raises offer, highlighting flurry of deals

The Associated Press · May 19, 2014 8:25 am

Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer

Board of British drugmaker AstraZeneca rejects new $119 billion takeover offer from Pfizer

Washington Examiner · May 19, 2014 6:46 am

Pfizer ups offer for AstraZeneca again, to $119B

Pfizer ups offer for AstraZeneca again, to $119B

Linda Johnson · May 19, 2014 4:06 am

Pfizer chief says jobs will go in takeover

Danica Kirka · May 13, 2014 3:44 pm

An exterior view of the Two Kingdom Street building which houses the headquarters of AstraZeneca, in the Paddington area of London, Friday, May 2, 2014. The board of pharmaceutical company AstraZeneca on Friday rejected drug maker Pfizer's sweetened takeover offer. Pfizer earlier in the day said it is offering 50 pounds ($84) a share in cash and stock, a 7.3 increase on a previous bid. The offer values AstraZeneca at $106 billion. (AP Photo/Matt Dunham)

AstraZeneca rejects sweetened Pfizer takeover bid

DANICA KIRKALINDA A. JOHNSON · May 2, 2014 9:34 pm

AstraZeneca board rejects sweetened takeover offer from Pfizer

AstraZeneca board rejects sweetened takeover offer from Pfizer

Washington Examiner · May 2, 2014 9:56 am

Pfizer still pursuing AstraZeneca after 2nd rebuff

Pfizer still pursuing AstraZeneca after 2nd rebuff

DANICA KIRKALINDA A. JOHNSON · April 28, 2014 6:59 pm

AstraZeneca shares soar on Pfizer interest

AstraZeneca shares soar on Pfizer interest

Danica Kirka · April 28, 2014 11:16 am

Pfizer Inc. proposed buying AstraZeneca Plc for about 58.8 billion pounds ($98.7 billion) in what would rank as the biggest-ever takeover of a U.K. company and continues to be interested in a deal after being spurned. (AP image)

Pfizer still wants AstraZeneca after $98.7 billion bid rejected

oliver-staley, phil-serafino · April 28, 2014 4:00 am

Pfizer to help investors with dividend, buybacks

Pfizer to help investors with dividend, buybacks

The Associated Press · April 24, 2014 9:08 pm

Under the FDA's expanded access program for investigational products, the agency has worked closely with the Centers for Disease Control and Prevention to make the unapproved MenB vaccine, Bexsero, available as quickly as possible for use on two college campuses. (Thinkstock)

FDA official: Agency is committed to timely approval of vaccines

karen-midthun · April 18, 2014 4:00 am